针刺调神对慢性持续期支气管哮喘患者生命质量的影响
|
摘要
支气管哮喘是内科临床上的常见病之一,属肺系疑难病症。支气管哮喘也是一种与心理社会因素关系密切的慢性疾病。目前,在针灸临床,哮喘发作期多采用单纯针灸疗法,并取得一定疗效,但重症仍依靠西医常规治疗。哮喘缓解期多选用灸法、穴位敷贴、穴位注射等,对减缓哮喘发作有积极的治疗意义。对针灸作用机制的研究,主要是集中在改善肺通气功能,提高机体免疫力等方面,作用机制复杂,仍有许多问题亟待解决。目前尚无根治哮喘的方法,控制哮喘复发,提高患者的生命质量是主要目标任务。本课题也是基于此目的,拟观察针刺调神治疗支气管哮喘慢性持续期作用的疗效,并初步探讨其作用机制。
目的：通过针灸治疗,初步观察针刺调神治疗慢性持续期支气管哮喘的临床疗效,并初步探讨本法治疗哮喘的作用机制。
方法：
分组：将试验病例随机分为治疗组(常规取穴加调神腧穴)和对照组(常规取穴)每组各30例。
选穴：主穴：对照组：肺俞、定喘、膻中、列缺、尺泽、合谷。治疗组：在对照组取穴的基础上,加百会、印堂、内关、太冲。配穴：脾虚证加脾俞；肾虚证加肾俞；鼻塞流鼻涕加迎香；咳嗽痰多加丰隆；喘甚加天突。针刺操作：两组患者治疗均以主穴为主,酌加配穴。患者先行仰卧位,针刺胸前部腧穴,得气后行平补平泻手法10秒,留针15分钟。留针过程中,行针1次,每次提插捻转约10秒钟,以促使再次得气或使针感得到加强。然后行腑卧位,针刺背部脊柱两侧腧穴,其它操作同上
观察指标：1.情绪状态指标：用焦虑自评量表(self- rating anxiety scale, SAS)和抑郁自评量表(selfrating depression scale、SDS)两项评价哮喘患者治疗前后的情绪状态。
2.生命质量测评：采用支气管哮喘生命质量调查问卷(asthma quality of life questionnaire, AQLQ)评价哮喘患者治疗前后的生命质量变化；
3.哮喘症状评价：采用哮喘日记表,评价夜间症状和白天症状的状况。
4.哮喘相关量表：用哮喘控制测试(sthma control test, ACT)观察哮喘控制情况。
5.肺功能检测：用第一秒用力呼气容积(forced expiratory volume in one second, FEV1)和FEV1/FVC (forced vital capacity,用力肺活量)观察哮喘患者治疗前后肺功能变化。
结果：
1.两组患者情绪状态(SAS、SDS)积分比较：
(1)两组全部患者,组间及各组治疗前后SAS、SDS积分比较：经3个月治疗后,治疗组SAS和SDS分值均显著下降(P<0.05),对照组仅SDS分值明显下降(P<0.05)；治疗后,两组间SAS分值和SDS分值均有明显差异(P<0.05),治疗组SAS分值和SDS分值下降幅度较对照组为显著。结果表明,治疗组患者的焦虑程度较治疗前明显减轻,对照组无明显变化；两组穴方均可改善患者抑郁症状,但治疗组在改善焦虑抑郁程度方面明显优于对照组。
(2)两组有焦虑抑郁状态(SAS积分>45或SDS积分>50)的患者,组间及各组治疗前后SAS和SDS积分比较：针刺治疗3个疗程后,治疗组SAS分值和SDS分值均明显下降(P<0.05)；对照组SAS分值无明显变化(P>0.05),SDS分值明显下降(P<0.05)；治疗后两组间SAS分值、SDS分值均有显著性差异(P<0.05),治疗组下降显著。结果提示,治疗组患者的焦虑程度明显减轻,对照组焦虑程度无明显改变,两种穴方均可使患者抑郁症状改善,说明治疗组在改善SAS分值和SDS分值方面优于对照组,且改善焦虑抑郁程度较对照组明显。
2.两组患者生命质量积分比较：
(1)两组全部患者,组间及各组治疗前后AQLQ积分比较：经3个疗程治疗后,与本组治疗前比较,治疗组在改善AQLQ总分、活动受限(A分)、症状影响(B分)、情感功能(C分)及环境刺激(D分)均有统计学差异(P<0.05),积分明显上升。对照组总分和A分、B分、C分组积分明显上升(P<0.05)。治疗组A分明显高于对照组。结果提示,两组患者治疗后的生命质量整体状况都有改善,治疗组在改善活动受限方面优于对照组。
(2)两组有焦虑抑郁状态患者,组间及各组治疗前后AQLQ积分变化比较：经3个疗程治疗后,与本组治疗前比较,两组治疗后AQLQ积分均明显升高(P<0.05),说明两组焦虑抑郁状态患者治疗后生命质量整体状况都有改善。进一步评价AQLQ各个能区,结果提示：与本组治疗前比较,治疗组A分、B分、C分、D分积分均明显上升(P<0.05),表明有精神障碍状态患者治疗后的活动受限、症状影响、情感功能和环境刺激方面都有改善；对照组的A分、B分、D分积分均上升(P<0.05),C分无明显变化(P>0.05),提示有精神状态患者治疗后除情感功能无明显改善外其余均有提高。治疗后两组差值比较AQLQ总分、A分、B分、C分均有统计学差异(P<0.05),D分积分差值无统计学意义(P>0.05),说明治疗组在改善活动受限、症状影响、情感功能方面优于对照组。
3.两组患者临床症状(白天和夜间症状日记)积分比较：
(1)两组全部患者,组间及各组治疗前后日记症状积分比较：针刺治疗3个疗程后,患者治疗前后白天和夜间症状积分变化显示,与治疗前相比,治疗后两组患者白天和夜间症状积分都明显下降(均P<0.05),两组间白天和夜间症状积分均无明显差异(P>0.05)。提示治疗组与对照组穴方都能明显改善和哮喘有关的白天和夜间症状。(2)两组有焦虑抑郁状态的患者,组间及各组治疗前后日记症状积分比较：针刺治疗3个疗程后,治疗组治疗后较治疗前白天和夜间症状积分均明显下降,(P<0.05)；对照组治疗后白天和夜间症状积分均无明显下降,(P>0.05)；治疗后,组间比较,治疗组积分较对照组明显下降(P<0.05)。
4.哮喘控制测评：采用ACT哮喘控制测量表测评,治疗3个疗程后,两组全部患者,治疗前后ACT积分均明显的升高(P<0.05)。表明两组穴位都有控制哮喘症状的疗效；对两组患者中有精神障碍状态者治疗前后的积分进行比较,治疗组在改善ACT积分方面优于对照组。
5.两组患者肺功能变化比较：
(1)两组全部患者,组间及各组治疗前后肺功能变化比较：针刺治疗3个疗程后,与本组治疗前比较,两组患者的肺功能指标FEV1&、FEV1/FVC%均明显升高(均P<0.05)；治疗后两组间比较,FEV1%、FEV1/FVC%及治疗前后组内差值无明显差异(P>0.05)。结果说明,两组穴方均能明显改善哮喘患者的肺功能。
(2)两组有焦虑抑郁状态患者,组间及各组治疗前后肺功能变化比较：针刺治疗3个疗程后,与本组治疗前比较,两组患者的肺功能指标FEV1%、FEV1/FVC%均明显升高(均P<0.05)；治疗后两组间FEV1%、FEV1/FVC%及治疗前后组内差值均无明显差异(P>0.05)。结果表明,伴有焦虑抑郁状态的两组哮喘患者,经针刺治疗后,肺通气功能均明显改善,但两组之间肺通气功能的改善无明显差异。
结论：
1.针刺调神能够改善有焦虑抑郁状态哮喘患者的焦虑和抑郁症状,对照组穴方仅能改善有抑郁状态患者的抑郁症状。提示有焦虑抑郁状态哮喘患者加用调神穴位进行治疗,能够明显减少焦虑和抑郁的症状,获到最佳的疗效。
2.针灸调神治疗能够改善有精神障碍状态的哮喘患者活动受限,症状影响,情感功能,环境刺激状况,提高哮喘患者整体生命质量；在改善活动受限、症状影响、情感功能方面较常规针刺治疗有一定的优势。
3.针刺调神能够减轻有精神障碍状态哮喘患者的白天症状和夜间症状,针刺调神较常规针刺治疗在减轻有精神障碍状态哮喘患者的白天症状和夜间症状方面具有明显的疗效优势。
4.针灸调神和常规治疗均能改善哮喘患者和有精神障碍状态哮喘控制的疗效,但在有精神障碍状态患者当中治疗组穴方的哮喘控制优于对照组。哮喘患者哮喘控制情况均得到改善,并且与肺功能检测结果有较好的相关性。
5.针灸调神和常规针刺治疗均能改善哮喘患者和有精神障碍状态的哮喘患者的肺通气功能,减少气道阻力。两种穴方在改善肺通气功能方面无明显差异。
Bronchial asthma, a refractory respiratory condition, is prevalent among internal medicine diseases. It is a chronic condition closely related to psychosocial effects. While acupuncture treatment on asthma onset is effective, severe attack requires conventional medical management. During remission periods, different acupuncture technics can be applied such as: moxibustion, topical application on acupuncture points and acupuncture point injection. Research about the mechanism of acupuncture in ventilation improvement and immune system strengthening is complex and there are remaining problems that need to be solved. In absence of a complete cure, the present goals of asthma treatment are asthma relapse control and life quality improvement. The present research objective is the observation of the mechanism of mind regulating in the acupuncture treatment of persistent chronic bronchial asthma.
Objective:observation of the mind regulating method in the acupuncture treatment of persistent chronic bronchial asthma was implemented in order to obtain a comprehensive evaluation of its mechanism and efficacy.
Methods:Subjects were randomly distributed in the treatment group (selection of points for the mind regulation in addition to points for standard asthma treatment) and in the control group (selection of points for standard asthma treatment) with 30 subjects in every group. Point selection criteria:main prescription points for the control group were BL13 Feishu, EX-B1 Dingchuan, CV17 Shanzhong, LU7 Lieque, LU5 Chize and LI4 HeGu. As for the treatment group GV20 BaiHui, EX-HN3 YinTang, PC6 Neiguan and LR3 TaiChong were added to the points prescribed in the control group main prescription. For each group associated points were added:BL20 Pishu (for spleen deficiency pattern), BL23 Shenshu (for kidneys deficiency pattern). LI20 Yingxiang in case of nasal obstruction or rhinorrhea, ST40 Fenglong in case of cough with expectoration, Tian Tu in case of severe dyspnea. Needling techniques:in both groups the points belonging to the main prescription were used systematically, as for the associated points they were selected according to the symptomatology. Points located on the thoracic area were inserted first with the patient lying supine. After the Qi response was obtained on the acupuncture point, a neutral stimulation was applied on each point for about 10 seconds and thereafter the needles were left in situ for 15 minutes. During that interval each needle was manipulated once, combining rotating with the thrusting and pulling technique for about 10 seconds on each point in order to strengthen the Qi response and increase the needle sensation. Afterwards the operation was repeated again for the points located on the dorsal area, following the same protocol as above. Indicators:1) Emotional state indicators:Zung Self-Rating Anxiety Scale (SAS) and Zung Self-Rating Depression Scale (SDS) were used to evaluate the asthmatic patient emotional condition before and after treatment.2) Life quality evaluation:The Asthma Quality of Life Questionnaire (AQLQ) was used to evaluate the asthma patient quality of life before and after treatment.3) Asthma symptoms:the asthma diary was used to evaluate night and day time asthma symptoms.4) Assessment tables:Asthma Control Test (ACT) was used to evaluate the state of asthma control.5) Pulmonary function testing:forced expiratory volume in one second (FEV1) and the ratio of FEV1 to the forced vital capacity (FEV1/FVC) were used to evaluate the pulmonary function before and after treatment.
Results:1.Comparing emotional states:1) comparing global level of anxiety with SAS scores in both groups after 3 month of treatment. In the treatment group both SAS and SDS showed an evident drop in scores (P<0.05), as for the control group there was an evident drop in SDS scores (P<0.05). Comparing SAS and SDS scores, between the two groups, showed a significant difference (P<0.05) and both SAS and SDS drop in scores were more evident in the treatment group. The results indicate that there is an evident improvement in the level of anxiety for the patient in the treatment group which is not the case for the control group. Point from both prescriptions can improve depressive symptoms, but the effectiveness in reducing anxiety and depression is superior in the treatment group.
2) Comparing patients with anxiety and depression disorders in both groups (SAS积分>45、SDS积分>50) showed a drop in SAS and SDS scores for asthmatic patients with mental disorder belonging to the treatment group (P<0.05). There was no evident drop in the SAS scores in the control group (P>0.05) but the SDS scores did drop significantly (P<0.05). There was a significant difference in SAS and SDS drops after treatment between the two groups (P<0.05), the treatment group showed a significant drop in scores. This indicates that for the patients in the treatment group the anxiety level was reduced significantly, as for the control group there was no significant reduction. Both group point prescription can improve depressive symptoms.This result indicates that the treatment group does have a major improvement in SAS and SDS scores compared to the control group with a higher improvement of the levels of anxiety and depression.
2. Evaluating quality of life:1) comparing AQLQ scores within every group after three treatment periods showed an improvement in both groups for overall AQLQ scoring. The treatment group in its AQLQ sub groups:activity reduction (subgroup A), symptoms influence (subgroup B), emotional function (subgroup C) and environment stimuli (subgroup D) showed a significant score increase after treatment (P<0.05). The control group AQLQ subgroups A, B and C showed a significant score increase after treatment (P<0.05). Results were higher in A subgroup with the treatment group compared to the control group. This indicates an improvement of life quality after treatment in both the treatment group and control group patients and that the treatment group had a superior efficacy in improving patient movement limitations compared to the control group.2) comparing AQLQ scores in patients with mental disorders (SDS>50 or SAS>45) in every group showed a rise in overall AQLQ scoring after three treatment periods within either the treatment group and the control group (P<0.05). This indicates an improvement of life quality, in patient with mental disorders, after treatment in both the treatment group and control group. As for evaluating AQLQ subgroups within the treatment and control group, scoring rose significantly (P<0.05) for A, B, C and D subgroup in the treatment group indicating an improvement in movement limitation, symptom influence, emotional function and environment stimuli in patients with mental disorders. As for the control group there was a significant score rise in subgroup A. B and D (P<0.05) with no significant score rise in the C subgroup (P>0.05). This indicates that there was an improvement in all areas, for patients with mental disorders, except for emotional function area. Comparing the difference between the two groups after treatment showed that there was a significant difference for overall scoring as well as A, B and C subgroups (P<0.05), as for D subgroup there was no significant difference (P>0.05) which indicates that the treatment group has major efficacy in improving the patient movement limitation, symptoms influence and emotional function compared to the control group.
3. Comparing clinical symptoms:1) comparing night time and day time overall symptoms scores in both groups. Comparing the results before and after a 3 month treatment course, scores dropped significantly in both the treatment group and the control group (P<0.05), there was no significant difference in night time and day time symptom scoring between the two groups (P>0.05). This indicates that both group point prescription can improve significantly asthma related night time or day time symptoms.2) Comparing scores changes in patients with anxiety and depression disorders in both groups (SAS>45、SDS>50) before and after treatment. The treatment group showed an evident drop in scores in night time and day time symptoms after treatment (P<0.05), among the patients with mental disorders, which was not the case with the control group (P>0.05). Comparing the results between the two groups after treatment showed an evident major drop of scores in the treatment group compared to the control group.
4. Asthma control evaluation:Asthma Control Test was used to evaluate overall score changes in each group. After three treatment periods there was a significant rise in ACT scores in both the treatment group and the control group (P<0.05) which indicates that prescription points from both groups have a positive effect in the control of asthma symptoms. As for patients with mental disorders, both groups also showed evident rise in overall scores after treatment (P<0.05) with a higher scoring in the control group compared to the control group.
5. Comparing pulmonary function:1) comparing pulmonary function changes in every group before and after treatment showed that, after three treatment periods, there was an index increase in pulmonary function FEV1%,FEV1/FVC% in both the treatment group and the control group (P<0.05). Comparing pulmonary function results after treatment between the treatment group and the control group as well as the difference in each group before and after the treatment, did not show any significant difference (P>0.05). This indicates that acupuncture points from both groups can improve asthmatic patient's pulmonary function.2) Pulmonary function index FEV1%, FEV1/FVC% showed significant increase after treatment (P<0.05), within each group, in patients with mental disorders (SDS>50 or SAS>45) in the treatment group as well as the control group. Comparing FEV1%,FEV1/FVC% after treatment, between the two groups, as well as the difference in each group before and after the treatment did not show any significant difference (P>0.05). This result indicates that there is a significant improvement in pulmonary ventilation, in asthmatic patients with mental disorders (SDS>50 or SAS>45), after acupuncture treatment with points from both groups and that the difference in pulmonary ventilation improvement between the two groups is not significant.
Discussion:1. Acupuncture treatment with the method of regulating the mind can improve anxiety and depression symptoms in patients suffering from anxiety and depression condition, but acupuncture points belonging to the control group can only improve depression symptoms in depressed patients. This indicates that there is a major efficacy in improving anxiety and depression symptoms, in asthmatic patients suffering from anxiety and depression condition, when applying the mind regulating method in acupuncture treatment.
2. The acupuncture method of regulating the mind can improve the movement limitations, the symptoms influence, the emotional function and environment stimuli in the asthmatic patients with mental disorders, thus improving his overall quality of life. Major efficacy in improving movement limitations, symptoms influence and emotional function was shown when applying the mind regulating points compared to the standard asthma group of points.
3. The acupuncture method of regulating the mind is efficient in reducing night time and day time symptoms in patients with mental disorders. Using the acupuncture method of regulating the mind has a major efficacy, compared to the standard asthma acupuncture treatment, in reducing day time and night time symptoms in patients with mental disorders.
4. The acupuncture method of regulating the mind and the standard asthma acupuncture treatment both can improve asthma control levels in asthmatic patients whether they suffer from mental disorders or not, but the improvement is more evident in patients with mental disorders when using points from the treatment group. The improvement of asthma control was correlated with the improvement of the pulmonary function.
5. The acupuncture method of regulating the mind and the standard asthma acupuncture treatment both can improve the ventilatory function and reduce airway resistance in overall patients and patients with mental disorders. In fact, there was no significant difference in ventilatory function improvement when selecting points from these two different prescriptions.
目的：通过针灸治疗,初步观察针刺调神治疗慢性持续期支气管哮喘的临床疗效,并初步探讨本法治疗哮喘的作用机制。
方法：
分组：将试验病例随机分为治疗组(常规取穴加调神腧穴)和对照组(常规取穴)每组各30例。
选穴：主穴：对照组：肺俞、定喘、膻中、列缺、尺泽、合谷。治疗组：在对照组取穴的基础上,加百会、印堂、内关、太冲。配穴：脾虚证加脾俞；肾虚证加肾俞；鼻塞流鼻涕加迎香；咳嗽痰多加丰隆；喘甚加天突。针刺操作：两组患者治疗均以主穴为主,酌加配穴。患者先行仰卧位,针刺胸前部腧穴,得气后行平补平泻手法10秒,留针15分钟。留针过程中,行针1次,每次提插捻转约10秒钟,以促使再次得气或使针感得到加强。然后行腑卧位,针刺背部脊柱两侧腧穴,其它操作同上
观察指标：1.情绪状态指标：用焦虑自评量表(self- rating anxiety scale, SAS)和抑郁自评量表(selfrating depression scale、SDS)两项评价哮喘患者治疗前后的情绪状态。
2.生命质量测评：采用支气管哮喘生命质量调查问卷(asthma quality of life questionnaire, AQLQ)评价哮喘患者治疗前后的生命质量变化；
3.哮喘症状评价：采用哮喘日记表,评价夜间症状和白天症状的状况。
4.哮喘相关量表：用哮喘控制测试(sthma control test, ACT)观察哮喘控制情况。
5.肺功能检测：用第一秒用力呼气容积(forced expiratory volume in one second, FEV1)和FEV1/FVC (forced vital capacity,用力肺活量)观察哮喘患者治疗前后肺功能变化。
结果：
1.两组患者情绪状态(SAS、SDS)积分比较：
(1)两组全部患者,组间及各组治疗前后SAS、SDS积分比较：经3个月治疗后,治疗组SAS和SDS分值均显著下降(P<0.05),对照组仅SDS分值明显下降(P<0.05)；治疗后,两组间SAS分值和SDS分值均有明显差异(P<0.05),治疗组SAS分值和SDS分值下降幅度较对照组为显著。结果表明,治疗组患者的焦虑程度较治疗前明显减轻,对照组无明显变化；两组穴方均可改善患者抑郁症状,但治疗组在改善焦虑抑郁程度方面明显优于对照组。
(2)两组有焦虑抑郁状态(SAS积分>45或SDS积分>50)的患者,组间及各组治疗前后SAS和SDS积分比较：针刺治疗3个疗程后,治疗组SAS分值和SDS分值均明显下降(P<0.05)；对照组SAS分值无明显变化(P>0.05),SDS分值明显下降(P<0.05)；治疗后两组间SAS分值、SDS分值均有显著性差异(P<0.05),治疗组下降显著。结果提示,治疗组患者的焦虑程度明显减轻,对照组焦虑程度无明显改变,两种穴方均可使患者抑郁症状改善,说明治疗组在改善SAS分值和SDS分值方面优于对照组,且改善焦虑抑郁程度较对照组明显。
2.两组患者生命质量积分比较：
(1)两组全部患者,组间及各组治疗前后AQLQ积分比较：经3个疗程治疗后,与本组治疗前比较,治疗组在改善AQLQ总分、活动受限(A分)、症状影响(B分)、情感功能(C分)及环境刺激(D分)均有统计学差异(P<0.05),积分明显上升。对照组总分和A分、B分、C分组积分明显上升(P<0.05)。治疗组A分明显高于对照组。结果提示,两组患者治疗后的生命质量整体状况都有改善,治疗组在改善活动受限方面优于对照组。
(2)两组有焦虑抑郁状态患者,组间及各组治疗前后AQLQ积分变化比较：经3个疗程治疗后,与本组治疗前比较,两组治疗后AQLQ积分均明显升高(P<0.05),说明两组焦虑抑郁状态患者治疗后生命质量整体状况都有改善。进一步评价AQLQ各个能区,结果提示：与本组治疗前比较,治疗组A分、B分、C分、D分积分均明显上升(P<0.05),表明有精神障碍状态患者治疗后的活动受限、症状影响、情感功能和环境刺激方面都有改善；对照组的A分、B分、D分积分均上升(P<0.05),C分无明显变化(P>0.05),提示有精神状态患者治疗后除情感功能无明显改善外其余均有提高。治疗后两组差值比较AQLQ总分、A分、B分、C分均有统计学差异(P<0.05),D分积分差值无统计学意义(P>0.05),说明治疗组在改善活动受限、症状影响、情感功能方面优于对照组。
3.两组患者临床症状(白天和夜间症状日记)积分比较：
(1)两组全部患者,组间及各组治疗前后日记症状积分比较：针刺治疗3个疗程后,患者治疗前后白天和夜间症状积分变化显示,与治疗前相比,治疗后两组患者白天和夜间症状积分都明显下降(均P<0.05),两组间白天和夜间症状积分均无明显差异(P>0.05)。提示治疗组与对照组穴方都能明显改善和哮喘有关的白天和夜间症状。(2)两组有焦虑抑郁状态的患者,组间及各组治疗前后日记症状积分比较：针刺治疗3个疗程后,治疗组治疗后较治疗前白天和夜间症状积分均明显下降,(P<0.05)；对照组治疗后白天和夜间症状积分均无明显下降,(P>0.05)；治疗后,组间比较,治疗组积分较对照组明显下降(P<0.05)。
4.哮喘控制测评：采用ACT哮喘控制测量表测评,治疗3个疗程后,两组全部患者,治疗前后ACT积分均明显的升高(P<0.05)。表明两组穴位都有控制哮喘症状的疗效；对两组患者中有精神障碍状态者治疗前后的积分进行比较,治疗组在改善ACT积分方面优于对照组。
5.两组患者肺功能变化比较：
(1)两组全部患者,组间及各组治疗前后肺功能变化比较：针刺治疗3个疗程后,与本组治疗前比较,两组患者的肺功能指标FEV1&、FEV1/FVC%均明显升高(均P<0.05)；治疗后两组间比较,FEV1%、FEV1/FVC%及治疗前后组内差值无明显差异(P>0.05)。结果说明,两组穴方均能明显改善哮喘患者的肺功能。
(2)两组有焦虑抑郁状态患者,组间及各组治疗前后肺功能变化比较：针刺治疗3个疗程后,与本组治疗前比较,两组患者的肺功能指标FEV1%、FEV1/FVC%均明显升高(均P<0.05)；治疗后两组间FEV1%、FEV1/FVC%及治疗前后组内差值均无明显差异(P>0.05)。结果表明,伴有焦虑抑郁状态的两组哮喘患者,经针刺治疗后,肺通气功能均明显改善,但两组之间肺通气功能的改善无明显差异。
结论：
1.针刺调神能够改善有焦虑抑郁状态哮喘患者的焦虑和抑郁症状,对照组穴方仅能改善有抑郁状态患者的抑郁症状。提示有焦虑抑郁状态哮喘患者加用调神穴位进行治疗,能够明显减少焦虑和抑郁的症状,获到最佳的疗效。
2.针灸调神治疗能够改善有精神障碍状态的哮喘患者活动受限,症状影响,情感功能,环境刺激状况,提高哮喘患者整体生命质量；在改善活动受限、症状影响、情感功能方面较常规针刺治疗有一定的优势。
3.针刺调神能够减轻有精神障碍状态哮喘患者的白天症状和夜间症状,针刺调神较常规针刺治疗在减轻有精神障碍状态哮喘患者的白天症状和夜间症状方面具有明显的疗效优势。
4.针灸调神和常规治疗均能改善哮喘患者和有精神障碍状态哮喘控制的疗效,但在有精神障碍状态患者当中治疗组穴方的哮喘控制优于对照组。哮喘患者哮喘控制情况均得到改善,并且与肺功能检测结果有较好的相关性。
5.针灸调神和常规针刺治疗均能改善哮喘患者和有精神障碍状态的哮喘患者的肺通气功能,减少气道阻力。两种穴方在改善肺通气功能方面无明显差异。
Bronchial asthma, a refractory respiratory condition, is prevalent among internal medicine diseases. It is a chronic condition closely related to psychosocial effects. While acupuncture treatment on asthma onset is effective, severe attack requires conventional medical management. During remission periods, different acupuncture technics can be applied such as: moxibustion, topical application on acupuncture points and acupuncture point injection. Research about the mechanism of acupuncture in ventilation improvement and immune system strengthening is complex and there are remaining problems that need to be solved. In absence of a complete cure, the present goals of asthma treatment are asthma relapse control and life quality improvement. The present research objective is the observation of the mechanism of mind regulating in the acupuncture treatment of persistent chronic bronchial asthma.
Objective:observation of the mind regulating method in the acupuncture treatment of persistent chronic bronchial asthma was implemented in order to obtain a comprehensive evaluation of its mechanism and efficacy.
Methods:Subjects were randomly distributed in the treatment group (selection of points for the mind regulation in addition to points for standard asthma treatment) and in the control group (selection of points for standard asthma treatment) with 30 subjects in every group. Point selection criteria:main prescription points for the control group were BL13 Feishu, EX-B1 Dingchuan, CV17 Shanzhong, LU7 Lieque, LU5 Chize and LI4 HeGu. As for the treatment group GV20 BaiHui, EX-HN3 YinTang, PC6 Neiguan and LR3 TaiChong were added to the points prescribed in the control group main prescription. For each group associated points were added:BL20 Pishu (for spleen deficiency pattern), BL23 Shenshu (for kidneys deficiency pattern). LI20 Yingxiang in case of nasal obstruction or rhinorrhea, ST40 Fenglong in case of cough with expectoration, Tian Tu in case of severe dyspnea. Needling techniques:in both groups the points belonging to the main prescription were used systematically, as for the associated points they were selected according to the symptomatology. Points located on the thoracic area were inserted first with the patient lying supine. After the Qi response was obtained on the acupuncture point, a neutral stimulation was applied on each point for about 10 seconds and thereafter the needles were left in situ for 15 minutes. During that interval each needle was manipulated once, combining rotating with the thrusting and pulling technique for about 10 seconds on each point in order to strengthen the Qi response and increase the needle sensation. Afterwards the operation was repeated again for the points located on the dorsal area, following the same protocol as above. Indicators:1) Emotional state indicators:Zung Self-Rating Anxiety Scale (SAS) and Zung Self-Rating Depression Scale (SDS) were used to evaluate the asthmatic patient emotional condition before and after treatment.2) Life quality evaluation:The Asthma Quality of Life Questionnaire (AQLQ) was used to evaluate the asthma patient quality of life before and after treatment.3) Asthma symptoms:the asthma diary was used to evaluate night and day time asthma symptoms.4) Assessment tables:Asthma Control Test (ACT) was used to evaluate the state of asthma control.5) Pulmonary function testing:forced expiratory volume in one second (FEV1) and the ratio of FEV1 to the forced vital capacity (FEV1/FVC) were used to evaluate the pulmonary function before and after treatment.
Results:1.Comparing emotional states:1) comparing global level of anxiety with SAS scores in both groups after 3 month of treatment. In the treatment group both SAS and SDS showed an evident drop in scores (P<0.05), as for the control group there was an evident drop in SDS scores (P<0.05). Comparing SAS and SDS scores, between the two groups, showed a significant difference (P<0.05) and both SAS and SDS drop in scores were more evident in the treatment group. The results indicate that there is an evident improvement in the level of anxiety for the patient in the treatment group which is not the case for the control group. Point from both prescriptions can improve depressive symptoms, but the effectiveness in reducing anxiety and depression is superior in the treatment group.
2) Comparing patients with anxiety and depression disorders in both groups (SAS积分>45、SDS积分>50) showed a drop in SAS and SDS scores for asthmatic patients with mental disorder belonging to the treatment group (P<0.05). There was no evident drop in the SAS scores in the control group (P>0.05) but the SDS scores did drop significantly (P<0.05). There was a significant difference in SAS and SDS drops after treatment between the two groups (P<0.05), the treatment group showed a significant drop in scores. This indicates that for the patients in the treatment group the anxiety level was reduced significantly, as for the control group there was no significant reduction. Both group point prescription can improve depressive symptoms.This result indicates that the treatment group does have a major improvement in SAS and SDS scores compared to the control group with a higher improvement of the levels of anxiety and depression.
2. Evaluating quality of life:1) comparing AQLQ scores within every group after three treatment periods showed an improvement in both groups for overall AQLQ scoring. The treatment group in its AQLQ sub groups:activity reduction (subgroup A), symptoms influence (subgroup B), emotional function (subgroup C) and environment stimuli (subgroup D) showed a significant score increase after treatment (P<0.05). The control group AQLQ subgroups A, B and C showed a significant score increase after treatment (P<0.05). Results were higher in A subgroup with the treatment group compared to the control group. This indicates an improvement of life quality after treatment in both the treatment group and control group patients and that the treatment group had a superior efficacy in improving patient movement limitations compared to the control group.2) comparing AQLQ scores in patients with mental disorders (SDS>50 or SAS>45) in every group showed a rise in overall AQLQ scoring after three treatment periods within either the treatment group and the control group (P<0.05). This indicates an improvement of life quality, in patient with mental disorders, after treatment in both the treatment group and control group. As for evaluating AQLQ subgroups within the treatment and control group, scoring rose significantly (P<0.05) for A, B, C and D subgroup in the treatment group indicating an improvement in movement limitation, symptom influence, emotional function and environment stimuli in patients with mental disorders. As for the control group there was a significant score rise in subgroup A. B and D (P<0.05) with no significant score rise in the C subgroup (P>0.05). This indicates that there was an improvement in all areas, for patients with mental disorders, except for emotional function area. Comparing the difference between the two groups after treatment showed that there was a significant difference for overall scoring as well as A, B and C subgroups (P<0.05), as for D subgroup there was no significant difference (P>0.05) which indicates that the treatment group has major efficacy in improving the patient movement limitation, symptoms influence and emotional function compared to the control group.
3. Comparing clinical symptoms:1) comparing night time and day time overall symptoms scores in both groups. Comparing the results before and after a 3 month treatment course, scores dropped significantly in both the treatment group and the control group (P<0.05), there was no significant difference in night time and day time symptom scoring between the two groups (P>0.05). This indicates that both group point prescription can improve significantly asthma related night time or day time symptoms.2) Comparing scores changes in patients with anxiety and depression disorders in both groups (SAS>45、SDS>50) before and after treatment. The treatment group showed an evident drop in scores in night time and day time symptoms after treatment (P<0.05), among the patients with mental disorders, which was not the case with the control group (P>0.05). Comparing the results between the two groups after treatment showed an evident major drop of scores in the treatment group compared to the control group.
4. Asthma control evaluation:Asthma Control Test was used to evaluate overall score changes in each group. After three treatment periods there was a significant rise in ACT scores in both the treatment group and the control group (P<0.05) which indicates that prescription points from both groups have a positive effect in the control of asthma symptoms. As for patients with mental disorders, both groups also showed evident rise in overall scores after treatment (P<0.05) with a higher scoring in the control group compared to the control group.
5. Comparing pulmonary function:1) comparing pulmonary function changes in every group before and after treatment showed that, after three treatment periods, there was an index increase in pulmonary function FEV1%,FEV1/FVC% in both the treatment group and the control group (P<0.05). Comparing pulmonary function results after treatment between the treatment group and the control group as well as the difference in each group before and after the treatment, did not show any significant difference (P>0.05). This indicates that acupuncture points from both groups can improve asthmatic patient's pulmonary function.2) Pulmonary function index FEV1%, FEV1/FVC% showed significant increase after treatment (P<0.05), within each group, in patients with mental disorders (SDS>50 or SAS>45) in the treatment group as well as the control group. Comparing FEV1%,FEV1/FVC% after treatment, between the two groups, as well as the difference in each group before and after the treatment did not show any significant difference (P>0.05). This result indicates that there is a significant improvement in pulmonary ventilation, in asthmatic patients with mental disorders (SDS>50 or SAS>45), after acupuncture treatment with points from both groups and that the difference in pulmonary ventilation improvement between the two groups is not significant.
Discussion:1. Acupuncture treatment with the method of regulating the mind can improve anxiety and depression symptoms in patients suffering from anxiety and depression condition, but acupuncture points belonging to the control group can only improve depression symptoms in depressed patients. This indicates that there is a major efficacy in improving anxiety and depression symptoms, in asthmatic patients suffering from anxiety and depression condition, when applying the mind regulating method in acupuncture treatment.
2. The acupuncture method of regulating the mind can improve the movement limitations, the symptoms influence, the emotional function and environment stimuli in the asthmatic patients with mental disorders, thus improving his overall quality of life. Major efficacy in improving movement limitations, symptoms influence and emotional function was shown when applying the mind regulating points compared to the standard asthma group of points.
3. The acupuncture method of regulating the mind is efficient in reducing night time and day time symptoms in patients with mental disorders. Using the acupuncture method of regulating the mind has a major efficacy, compared to the standard asthma acupuncture treatment, in reducing day time and night time symptoms in patients with mental disorders.
4. The acupuncture method of regulating the mind and the standard asthma acupuncture treatment both can improve asthma control levels in asthmatic patients whether they suffer from mental disorders or not, but the improvement is more evident in patients with mental disorders when using points from the treatment group. The improvement of asthma control was correlated with the improvement of the pulmonary function.
5. The acupuncture method of regulating the mind and the standard asthma acupuncture treatment both can improve the ventilatory function and reduce airway resistance in overall patients and patients with mental disorders. In fact, there was no significant difference in ventilatory function improvement when selecting points from these two different prescriptions.
引文
[1]郑健,郭云霞,林青,等.活血通络法配合西医治疗小儿哮喘发作期(热型)30例[J].山东中医药大学学报,2002.26(5)：354-355.
[2]王骏或,叶伟成.论温阳化瘀治哮喘[J].上海中医药杂志,1994,(9)：17-18.
[3]张蕴卓,刘贵颖.支气管哮喘的中医治疗进展[J].天津中医药大学学报,2006,25(4)：238-239.
[4]李传方,高尔鑫.哮喘病因病机及治则的探讨[J].安徽中医学院学报,1985,(4)：20-22.
[5]韩春生,张洪春.晁恩祥教授治疗哮喘病的经验[J].湖南中医药导报,1996,2(1)：9-10.
[6]孙继铭,薄庆,申兆义.从内风论治支气管哮喘90例分析[J].实用中医内科杂志,2003,17(5)：73.
[7]严桂珍,余传星,李希.益肾补肺平喘汤治疗支气管哮喘发作期42例临床观察[J].中国中医药科技,2000,7(6)：382-383.
[8]张丽玲.从治疗喘证2344人次中观察疏肝解郁法的疗效[J].江西中医药,1989,(2)；40.
[9]武维屏,贺福田.肝与咳、喘、哮[J].北京中医学院学报,1990,13(2)：11-13.
[10]高淑英.哮喘从肝肺论治探讨[J].中国中医药信息杂志,2006,13(8)：77.
[11]夏光欣.论肝与哮喘[J].陕西中医,1993,14(4)：161-162.
[12]王琳,田建辉.“痰饮伏肺”与哮喘病机[J].陕西中医,,2003,24(4)：334-336.
[13]贾仰民,宋康.中医学对哮喘的认识[J].光明中医,2010,25(5)：782-783.
[14]张洪春.祛风解痉法治疗哮喘病的临床研究[J].北京中医药大学学报,1995.18(4)：27-29.
[15]金亚明.祛风解痉汤治疗咳嗽变异性哮喘32例[J].黑龙江中医药,2008(1)：6-7.
[16]邢萍.宣肺降气汤治疗咳喘280例[J].河北中医,1993,15(1)：11-12.
[17]李霞,杜辕滨,江惠萍.降气定喘汤治疗支气管哮喘36例小结[J].甘肃中医,2002,15(2)： 31.
[18]杜宝荣.中西医结合内服外治治疗哮喘40例[J].四川中医,2004,22(6)：54.
[19]邵长荣,肖沪生,陈凤鸣,等.川芎嗪静脉滴注治疗发作期支气管哮喘[J].上海中医药杂志,1990,(8)：18-19
[20]崔红生,王小青,武维屏.升降散加减治疗支气管哮喘急性发作期临床观察[J]中国中医急症,2000,9(3)：96-97.
[21]张洁,施光其.黄芪六君子汤治疗哮喘缓解期85例临床观察[J].山东中医杂志,2004,23(4)：204-205.
[22]李向东,蒋雅萍,蔡寅寿.健脾益肺口服液治疗小儿哮喘缓解期50例[J].陕西中医,2003,24(6)：20-21.
[23]武维屏.调肝理肺法治疗哮喘174例临床观察[J].北京中医学院学报,1990,9(4)：19.
[24]郑彩霞.调肝理肺法治疗支气管哮喘85例临床观察[J].中医药临床杂志,2004,16(4)：311-312.
[25]赵四林,范伏元,贺选玲,等.加味二仙丸治疗支气管哮喘缓解期疗效观察[J].中国中医药信息杂志,2006,13(5)：59-60.
[26]林汉生.中西医结合治疗支气管哮喘慢性持续期临观察[J].实用中医药杂志,2005,21(5)：28.
[27]宋传荣.运用通腑法治疗慢性支气管炎的体会[J].现代中医药,2005,2：14-15.
[28]宋诵文.温肾健脾祛痰法控制支气管哮喘复发30例——附核酪注射液治疗对照22例[J].浙江中医杂志1998,33(1)：28-29.
[29]刘仁慧,袁颖,郭忻.哮喘缓解期治疗宜肺脾肾三脏并补[J].现代中西医结合杂志,2004,13(24)：141.
[30]李学明.中西医结合治疗缓解期支气管哮喘疗效观察[J].河北中医,2006,28(2)130-131.
[31]吴艳华.专科专病名医临证经验丛书2呼吸病[M].第2版.北京：人民卫生出版社,2006：142.
[32]张丽玲,李银珍,刘韶景.中医疏肝解郁法治疗喘证的研究[J].现代诊断与治疗,1993,4(1)：38-39.
[33]黄忠远,杨军平,邱丽瑛.解郁定喘汤治疗情志性支气管哮喘22例疗效观察[J].山东医药,2008,48(15)：61.
[34]张军,鲁焱.泻肺清肝饮治疗哮喘热哮证的疗效观察[J].湖北中医杂志,2010,32(9)：28-29.
[35]李淑霞,仝连伟,卢建华,等.哮喘患者生活质量与其应对方式和社会支持的相关性研究[J].护理学杂志,2007,22(15)：25-27.
[36]Kuo-An Chu, Yi-Chin Wu, Min—Hsim, Hong-Chung Wang. Acupuncture resulting in immediate bronchodilating response in asthma patients[J]. J Chin Med Assoc,2005,68(12): 591-594.
[37]马文珠,王莹.针刺和穴贴治疗支气管哮喘47例临床比较[J].中国针灸,2000,8(22)：455-456.
[40]老昌辉.自血混合丙球穴注治疗哮喘的临床观察[J].中国针灸,1995,15(6)：5-6,60.
[41]马淑兰,杨永清,崔龙萍,等.针刺血清对高嗜酸性粒细胞血症大鼠外周血嗜酸粒细胞数目的影响[J].针刺研究,2002,27(2)：65-68.
[42]Fan H, Sun B, Gu Q, et al. Oxygen radicals trigger activation of NF-kappaB and AP-1 and upregulation of IL-4 in reperfused canine heart [J]. Am J Physiol Heart Circ Physiol, 2002,282(5):H1778-1786.
[43]杨永清,陈汉平,王瑞珍,等.针刺对哮喘患者外周血活化T淋巴细胞与嗜酸性粒细胞的影响[J].上海针灸杂志,1995,14(2)：11-12.
[44]赖新生,李月梅,张家维.天灸对哮喘患者血清可溶性IL-2受体及T淋巴细胞亚群的影[J].中国针灸2000,20(1)：33-35.
[45]康晓娥,卓玉翠,赵福气,等.化脓灸对支气管哮喘发作期血浆中白三烯C4的影响[J].湖南中医杂志,2000,16(3)：33.
[46]马建吟,陆珊华,孙爱民.激光针疗改善过敏性豚鼠支气管滑肌功能的实验研究[J].江苏中医,2000,21(9)：45-46.
[47]王燕,刘艳艳,杨永清,等.针灸治疗支气管哮喘的实验研究进展[J].甘肃中医,2006,19(5)：40-43.
[48]戴文军,赖新生.天灸疗法对支气管哮喘患者血浆SP和VIP含量的影响[J].针刺研究,2001,26(2)：134-137.
[49]何扬子.激光灸治疗支气管哮喘的机理探讨[J].中国针灸1996,16(12)：7-9.
[50]蔡志红,董宇翔,刘放,等.针刺“清喘穴”即刻止喘多中心对照研究[J]中国针灸,2005,25(6)：383-386.
[51]张智龙,吉学群,薛莉,等.针刺治疗支气管哮喘急性发作期临床观察[J].中国针灸, 2005,25(3)：158-160.
[52]万文蓉.温阳利气法针灸治疗哮喘30例临床观察[J]中国针灸,2001.21(11)：649-650.
[53]李俊,赵吉平.电针肺俞穴为主治疗支气管哮喘急性发作期30例[J].中国民间疗法,2005,13(5)：15.
[54]孙玉霞,张争昌.罐针结合治疗哮喘急性发作129例观察[J].陕西中医学院学报,1998,21(4)：25-26.
[55]黄铁军,张吉,蔡普旺.针刺对哮喘患者外周血单个核细胞培养上清中IL—4分泌活性血清总IgE水平的影响[J].针刺研究,2000,25(4)：292-295.
[56].王丹华,卢锦花.单纯针刺、针刺结合穴位埋线疗法对支气管哮喘305例疗效观察[J].针灸临床杂志,1998,14(7)：32-34.
[57]董洪魁,范哗.刺络拔罐法治疗慢性哮喘46例[J].四川中医,2000,18(4)：55.
[58]徐懋兴,梁玉风.辨证施针治疗哮喘67例的疗效观察[J].针灸临床杂志,1994,10(2)：11-12.
[59]赵吉平,崔红生.温和灸治疗支气管哮喘缓解期36例疗效观察[J].中国民间疗法,2002,10(4)：22.
[60]洪建云.化脓灸治疗支气管哮喘临床研究[J].针灸临床杂志,2005,21(8)：39-40.
[61]刘明清,黄启嵩,尤斌.化脓灸治疗支气管哮喘的临床疗效观察[J].中国针灸,2002,22(8)：34-36.
[62]刘建平,徐斌,杨彬.穴位对氨茶碱经皮吸收的影响[J].中国针灸,2003,23(6)：355-357.
[63]宣丽华,徐福,张舒雁,等.穴位贴敷加穴位注射防治支气管哮喘的临床研究[J].中国针灸,2002,22(7)：9-11.
[64]王永兴,应延风,郭耿仁.曲安缩松穴位注射对哮喘患者肺功能改善作用[J].现代中西医结合杂志,2001,10(2)：95-96.
[65]侯小藏,王淑华.斯奇康穴位注射治疗哮喘58例[J].四川中医,2002.20(8)：81.
[66]雷励.穿山龙注射液穴位注射治疗重症支气管哮喘临床观察[J].中国中医急症,2005,14(5)：419,424.
[67]王强,李开选.定喘穴注射灭活卡介苗治疗支气管哮喘的观察[J].中国实用乡村医生杂志,2005,12(4)：41-42.
[68]李克刚.耳穴贴压治疗支气管哮喘58例[J].中国针灸,2000,20(11)：46.
[69]邢剑秋,韩燕.耳针从肝论治咳嗽性哮喘39例[J].江苏中医,2000,21(11)：44.
[70]田从豁,李以松,杨宏.皮下埋针治疗哮喘的初步观察[J].中国针灸,2002,22(3)：150-154.
[71]于雯,房恭,杨慎峭,等.火针对哮喘患者肺功能、IgE的影响及机制探讨[J].四 川中医,2004,22(12)：9-11.
[72]房恭火针对哮喘患者IL-4、IFN-γ的影响及机制探讨[J].山东中医药大学学报,2006,30(4)：304-305.
[73]杜善侠,吴延逊,崔联民.梅花针加艾灸治疗哮喘120例[J].中国针灸,2002,22(4)：221.
[74]陈月琴.梅花针加艾灸治疗支气管哮喘临床观察[J].实用中医内科杂志,2008,22(12)：96.
[75]李洁,魏建子,刘世敏.针灸治疗支气管哮喘的选穴用穴规律探析[J].针刺研究,2000,25(1)：78-80.
[76]刘立公,顾杰.哮喘的古代针灸治疗特点分析[J].上海针灸杂志,2000,19(5)：45-46.
[77]李俊.针灸治疗支气管哮喘临床研究思路[J].辽宁中医杂志2005,32(8)：823-824.
[78]Darko DF, Risch SC, Gillin JC, Golshan S. Association of beta-endorphin with specific clinical symptoms of depression[J]. Am J Psy chiatry,1992; 149 (9):1162-1167.
[79]Wenhe Z, Hechun L, Yucun S. The effect of electric acupuncture treatment on urinary MHPG-sulphate execretion in unmedicated schizophrenics[J]. Inter J Neuroscience,1981,14(3-4):179-182.
[80]王晓明,杨德本,黄慧,等.重复经颅磁刺激治疗抑郁症的初步研究[J].中华精神科杂志,2003,36(3)：50.
[81]廉南,雷中杰.针刺四神聪为主治疗厄瓜多尔籍焦虑症患者临床观察[J].成都中医药大学学报,,2001,24(3)：51-52.
[82]刘兰英,陆倩,王玲玲.电针对抑郁症患者氟西汀副作用的影响[J].浙江中医药大学学报,2007,31(4)：484-485.
[83]刘桂珍,藏云娟,刘爱珍.针灸加系统脱敏疗法治疗焦虑性神经症的疗效观察[J].上海针灸杂志,1998,17(4)：17-18.
[84]张民英.30例针罐结合治疗抑郁症的体会[J].中国实用医药.2007,2(33)：146.
[85]崔金波.针灸与心理疗法综合治疗抑郁发作36例[J].天津中医药,2003,20(2)65-66.
[86]庄礼兴,徐世芬.穴位埋线治疗抑郁性神经症47例临床观察[J].广州中医药大学学报,2009,26(1)：38-40.
[87]Kuo-An Chu, Yi-Chin Wu, Min-Hsim, Hong-Chung Wang. Acupuncture resulting in immediate bronchodilating response in asthma patients[J]. J Chin Med Assoc,2005,68(12): 591-594.
[88]金光亮；周东丰；苏晶；电针对慢性应激抑郁模型大鼠脑单胺类神经递质的影响[J].中华精神科杂志,1999；32(4)：220-222.
[89]郝伟.精神病学[M].4版,北京：人民卫生出版社.2001：119.
[90]张昶,谭程,高丹,等.近30年国内体针治疗支气管哮喘随机对照临床试验选穴及疗程设定规律分析[J].北京中医,2010,29(8)：571-574.
[91]杨甲三.针灸学[M].北京：人民卫生出版社,1997：69,352,276.
[92]陈华德,金灵青,娄冉,张丽敏.百会穴电针和埋线对慢性应激抑郁模型大鼠行为学及血清CORT和ACTH的影响[J].上海针灸杂志,2010：29(4)：244-247.
[1]Gerritsen J.Follow-up studies of asthma from childhood to adulthood[J].Paediatr Respir Rev,2002,3(3):184-192.
[2]程志英,王国洪,舒柳英,等.支气管哮喘与遗传和环境因素的关系[J].中国自然医学杂志,2003,5(2)：70-72.
[3]叶任高.内科学[M].4版,北京：人民卫生出版社,2001：32-33.
[4]王文莉,林洁英,林若玲.汕头市小儿支气管哮喘的吸入性变应原分析[J].河北医学,2005,10：46-47.
[5]Holtzman MJ, Agapov E, Kim E, et al. Developing the epithelial, viral, and allergic paradigm for asthma:Giles F. Filley lecture[J]. Chest,2003,123 (3 Suppl):377S-384S.
[6]Devereux G, Semon A.Diet as a risk factor for atopy and asthma[J].J Allergy Clin Immunol,2005,115(6):1109-1117.
[7]徐斌,王效道.心身医学[M].中国医药科技出版社,1986.
[8]Miller B D. Depression and asthma:a potentially lethal mixture [J]. J Allergy Clin Immunol 1987,80(3 Pt 2):481-486.
[9]Garden GM. Ayres J G. Psychiatric and social aspects of brittle asthma [J]. Thorax,1993, 48(5):501-505.
[10]Shih HZ. Eosinophils function as antigen-presenting cells[J]. J Leukoc Biol,2004,76 (3):520-527.
[11]Umetsu DT.Revising the immunological theories of asthma and allergy[J]. Lancet,2005,365(9454):98-100.
[12]李京培.在慢性哮喘患者血清中测定干扰素水平及其意义[J].中华医学检验杂志,1992,15(4)：212.
[13]James AL, Hogg JC,Dunn LA, et al. The use of the internal perimeter to compare airway-size and to calculate smooth muscle shortening[J]. Am Rev Respir Dis,1988,138 (1):136-139.
[14]武虹艳,万毅新,王晓平,等.轻、中度持续哮喘患者治疗前后气道高反应性及致气道重塑细胞因子变化研究[J].中国全科医生,2011,14(25)：58-60.
[15]Brew K,Dinakarpandian D,Nagase H. Tisse inhihit or metallop roteinase evolution, structure and function[J]. Biochim Biophys Acta,2000,1477(1-2):267-283.
[16]朱艳芬,宋泽庆,林磷.支气管哮喘小鼠气道重构模型的构建及评价[J].吉林大学学报(医学版),2010,36(1)：99-103.
[17]Crimi E, Spanevello A, Ind PW, et al. Dissoeiation between airway inflammation and airway hyperresponsiveness in allergie asthma[J]. Am ResPir Crit Care Med,1998; 157 (1):4-9.
[18]Kam JC, Szefler SJ, Surs w, et al. Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids[J]. J Immunol,1993,151(7): 3460-3466.
[19]Shih Z. Eosinophils function as antigen-presenting cells[J]. J Leukoc Biol,2004,76 (3): 520-527.
[20]Tomita K et al. Attenuated production of intracellular IL-10 and IL-12 in monocytes from patients with severe asthma[J].Clin Immunol,2002.102 (3):258-266.
[21]Ryan JJ. Interleukin-4 and its receptor:essential mediators of the allergic response[J]. J Allergy Clin Immunol,1997,99 (1 Pt 1):1-5.
[22]Barnes PJ. Effect of nedocromil sodium on platet-activating factor induced airway responses[J].J Allergy Clinl Immunol,1993,92(1 Pt2):187-189.
[23]陈康.哮喘的炎症反应过程及治疗[J].国外医学呼吸系统分册,1995,15(3)：146.
[24]殷凯生.支气管哮喘的现代论断与治疗[J].国外医学呼吸系统分册,2004,24(1)：55.
[25]孙红霞,李艳琴,于英.白三烯受体拮抗剂对哮喘治疗作用的研究[J].医学综述,2003,9(8)：16-17.
[26]Salvi SS, Krishna MT, Sampson AP, et al. The ati-inflammatory elects of leukotriene —modifying drugs and their use in asthma[J]. Chest,2001,119(5):1533-1546.
[27]罗文侗.支气管哮喘研究进展及存在问题[J].中华结核和呼吸杂志,1995,18(3)：131-132.
[28]梁冰岳,刘又宁.重新认识与评价B2肾上腺能受体激动剂[J].中华结核和呼吸杂志,1995,18(3)：133-134.
[29]Kips JC, O'Connor BJ, Inman MD, et al. A long-term study of the artiinflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma [J]. Am J Respir Crit Care Med,2000,161(3 Pt 1):996-1001.
[30]陈大鹏,万朝敏.循证医学关于儿童哮喘治疗中一些问题探讨[J].临床儿科杂志,2005,23(1)：55-56.
[31]Brown R. Behavioral issues in asthma management[J].Allergy Asthma Proc,2001, 22(2):67-69.
[32]Scott KM, Von Korff M, Ormel J, et al. Mental disorders among adults with asthma: results from the world Mental Health Survey[J]. Gen Hosp Psychiatry,2007;29(2):123-133.
[33]Brown ES, Vigil L, Khan DA,et al.A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder:a proof of concept study[J]. Biol psychiatry,2005,58(11):856-870.
[34]Ross CJ, Davis TM, MacDonald GF. Cognitive-behavioral treatment combined with asthma education for adults with asthma and coexisting panic disorder[J]. Clin Nurs Res.2005 May;14(2):131-157.
[35]蓝宇涛.212例支气管哮喘患者焦虑状况分析[J].华南预防医学,2003,29(4)35-37.
[36]Ten Thoren C, Petermann F. Reviewing asthma and anxiety [J]. Resp Med, 2000,94(5):409-415.
[37]Badura K, Brzoza Z, Gorezyca P, et al. Anxiety and depression in bronchial asthrna[J]. Psychiatr Pol,2001,35(5):755-762.
[38]Goldney RD, Ruffin R, Fisher IJ. Asthma symptoms associated with depression and lower quality of life:a population survey [J]. Med J Aust,2003,178 (9):437-441.
[39]Kim L.L, Simon L.B, Silvana B, et al. What is worse for asthma control and quality of life:depressive disorders, anxiety disorders, or both? Chest 2006,130 (4):1039-1047.
[40]Melissa Opolske, Lan Wilson.Asthma and depression:a pragmatic review of the literature and recommendations for future research[J].Clin Pract Epidemol Ment Health,2005,1:18-25.
[41]Oraka E, MPH; King ME, Callahan DB, Asthma and serious psychological distress: prevalence and risk factors among US adults,2001 2007[J]. Chest,2010;137(3):609-616.
[42]孙宏伟,童莉,尹风铃,等.支气管哮喘患者的心理健康状况及影响因素研究[J].中国行为医学科学,1999,8(3)：190-191.
[43]Vila G, Nollet-Clemencon C, de Blic J, et al. Prevalence of DSM IV anxiety and affective disorders in a pediatric population of asthmatic children and adolescents [J]. J Affect Disord. 2000,58(3):223-231.
[44]王鑫,张亚京,梁昆仑,等.支气管哮喘患儿心理学特点及整合性心理治疗对其疗效影响[J].实用儿科临床杂志,2007,22(21)：1627-1629.
[45]刘春红,段熙明,石寿森,等.支气管哮喘患者的生存质量及相关因素[J].中国心理卫生杂志,2007,21(8)：553-555,562.
[46]李毅精.心理社会因素在哮喘发作中的作用[J].中华结核和呼吸杂志,1998：11：134.
[47]王琳,蔡映云,秦兴国,等.哮喘患者的心理情绪与社会支持[J].中华内科杂志,2000,39(3)：192-193.
[48]杨菊贤,张锡明.实用心身疾病学[M].乌鲁木齐：新疆科技卫生出版社,1992：155.
[49]Rietveld SP, Prins PJ. The relationship between negative emotions and acute subjective and objective symptoms of childhood asthma[J]. March,1998,28(2):407-415.
[50]Van Sciver MM, D'Angelo EJ, Rappaport L. Pediatric compliance and the roles of distinct treatment characteristics, treatment attitudes, and family stresss:a preliminary report [J]. J Dev Behav Pediatr,1995,16(5):350-358.
[51]何权瀛.社会心理因素在哮喘发病中防治中的作用[J]中华结核和呼吸杂志,2001：24(9)：518-519.
[52]郭伟安,向平超,鞠立新,等.心理社会因素与支气管哮喘相关性研究[J].临床肺科杂志,2006,11(6)：18-19.
[53]闫巧焕,王红阳,吕英刚.社会心理因素在支气管哮喘发病中的作用[J].华北煤炭医学院学报,2006,8(3)：304-305.
[54]谢启文.现代神经内分泌学[M].上海：上海医科大学出版社,1999：169.
[55]石寿森,王晓芝,张兰,等.支气管哮喘心理社会因素与细胞因子及内皮素变化的关系[J].中国心理卫生杂志,2004,18(8)：527-530.
[56]Lehrer P M, Lsenberg S, Hochron S M. Asthma and emotion:a review [J]. J Asthma, 1993,30(1):5-21.
[57]商鸣宇,高元明,粱瑛,等.心理因素与支气管哮喘[J].北京医学,2002,24(4)： 55-56.
[58]汪辉,黄美健.生活事件焦虑抑郁对支气管哮喘发病影响的探讨[J].浙江实用医学,1996(1)：22-23.
[59]罗茂红,来则民,王栋.心身因素与儿童哮喘关系的研究[J].中国心理卫生杂志,2001,16(1)：58-59.
[60]Brown ES,Suppes T,Khan DA, et al. Mood changes duning prednisone burs in outpatients with asthma[J]. Clin Psychophamacol,2002,22 (1):55-61.
[61]Potoczek A. Difficult asthma stress and panic disorder[J]. Psychiatr Poi,2005,39(1):51-66.
[62]马迎教,林健燕.心理干预对哮喘患者心理及Th1 Th2平衡的影响[J].现代预防医学,2010,37(17)：3292-3294.
[63]麦贤弟,赵莉,檀卫平,等.哮喘患儿IL-12、 IL-13与总IgE水平变化[J].中山医科大学学报,2000,21(5)：400-402.
[64]兰大荣,冼乐武,梁宗安,等.心理治疗对哮喘常规干预的影响[J].华西医学,2002,17(1)：72-73.
[65]王贤才.呼吸系统疾病的最新进展[M].青岛：青岛出版社,1996：69-73.
[66]De MaroD sJ. Relaxation as a holistic nursing intervention[J]. Holist NurS Pract, 2000,14(3):30.
[67]支气管哮喘的定义、诊断、严重度分级及疗效判定标准(修正方案).中华结核和呼吸杂志,1993,16(增刊)：5.
[68]Grokker B. Effectiveness of combined relaxation exercises for children with bronchial asthma[J]. Kinderarztl Prax,1992,60 (1):12-16.
[69]杨华彬,汤艳清,何晓玲.渐进式放松疗法对学龄儿童支气管哮喘的疗效[J].中国行为医学科学,2004,13(6)：36-38.
[70]Freeman L W,Welton D. Effects of imagery,critical thinking,and asthma education on symptoms and mood state in adult asthma patients:a pilot study[J]. J Altern Complement Med,2005,11(1):57-68.
[71]张绍敏,孙丽,黄津芳.放松训练对哮喘病人干预效果研究[J].中华护理杂志,1999,34(4)：200-202.
[72]Huntley A, White AR, Ernst E. Relaxation therapies for asthma:a systematic review[J]. Thorax,2002,57(2):127-131.
[73]Melissa Opolske, Lan Wilson. Asthma and depression:a pragmatic review of the literature and recommendations for future research[J]. Clin Pract Epidemol Ment Health,2005,1:18-25.
[74]Lechin F, van der Dijs B,Orozco B, et al. The serotonin uptake-enhancing drug tianeptine suppresses in children:A double-blind, crossover, placebo-controlled study[J]. J Clin Pharmacol,1998,38 (10):918-925.
[75]梁可云.支气管哮喘患者抗抑郁治疗的临床观察[J].中国现代医药杂志,2008,10(2)：92-93.
[76]刘希华,周乃娥.健康教育对提高哮喘病人疾病认知与自控水平的研究[J].实用心脑肺血管病杂志,2002,10(6)：42-43
[1]郑吉善,李昌崇,陈庆武,等.卡介菌多糖核酸对哮喘小鼠胸腺活化调节趋化因子及mRNA表达的影响[J].中国药理学通报,2007,23(5)：666-671.
[2]张克敏,白兆芝.中医内科学[M].北京：科学出版社,2001：25.
[3]孙滨.哮喘发病机理与治疗进展[J].中华结核和呼吸杂志,1994,17(4)：197.
[4]郭雪君,邓伟吾.B2激动剂在治疗哮喘中存在的问题[J].中华结核和呼吸杂志,1994,17(4)：203-205.
[5]Chu KA,Wu YC, Tmg YM, Wang HC, Lu JY. Acupuncture therapy results in immediate bronchodilating effect in asthma patients. J Chin Med Assoc.2007,70(7):265-268.
[6]Miller B D. Depression and asthma:a potentially lethal mixture [J]. J Allergy Clin Immunol,1987,80:481-486.
[7]Ross C J, Davis T M, Macdonald G F. Cognitive-behavioral treatment combined with asthma education for adults with asthma and coexisting panic disorder. Clin Nurs Res,2005, 14(2):131-157.
[8]GINA EXECUTIVE COMMITTEE AND GINA SCIENCE COMMITTEE.GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION 2008[J].www.ginathma.org,2008:20-21.
[9]中华医学会呼吸病学分会.支气管哮喘防治指南、支气管哮喘的定义、诊断、治疗和管理方案[J].中华结核和呼吸杂志,2008,31(3)：177-185.
[10]李明华,殷凯生,蔡映云,主编.哮喘病学.人民卫生出版社.2005,2566叶任高,陆再英,主编.内科学.人民卫生出版社.2007,68
[11]中华人民共和国国家质量监督检验检疫总局,中国国家标准化管理委员会发布.腧穴名称与定位[M].北京：中国标准出版社,2006.
[12]McDowell I. Measuring health:a guide to rating scales and questionnaires [M]. Oxford University Press,2006:303-304,344-345.
[13]胡亚美,江载芳.实用儿科学[M].7版.北京：人民卫生出版社,2002：631-642.
[14]杨锡强,易著文.儿科学[M].6版.北京：人民卫生出版社,2003：193-198.
[15]全国儿童哮喘防治协作组.中国城区儿童哮喘患病率调查[J].中华儿科杂志,2003,41(5)：123-127.
[16]张压西,陈友梅,余红樱.针刺肺输穴改善肺功能时效关系研究[J].中国针灸,1997,17(10)：581-582,641.
[17]刘鑫,戴爱国,周继鹏,等.针刺对哮喘豚鼠肺内嗜酸细胞凋亡及Fas表达的影响[J].上海针灸杂志,2003,22(7)：3-5.
[18]孙占玲.王伟.膻中穴埋线对哮喘豚鼠气道炎症的影响[J].浙江中医杂志,2007.42(7)：392-393.
[19]邱为尉.列缺穴为主治疗寒痰[J].上海针灸杂志,1999.18(3)：12.
[20]陈丽仪,郭元琦,凌楠.高频电针神庭印堂穴治疗不寐临床观察[J].新中医,2001,33(10)：46-47.
[21]郭乃琴,聂鸿丹.针刺加电针治疗焦虑症30例[J].针灸临床杂志,2002,18(11)：38.
[22]Bacharier LB, Strunk RC, Mauger D, et al. Classifying Asthma Severity in Children[J]. Am J Respir Crit Care Med..2004,170:426-432.
[23]王又平.针灸治疗哮喘50例临床观察[J].光明中医,2008,23(1)：23-24.
[24]徐永健,谢俊刚.重视对支气管哮喘患者的生活质量评估.中华内科杂志,2005,44(5)：324-325.
[25]Yen IH, Yelin EH, Katz P, et al. Perceived neighborhood problems and quality of life, physical functioning, and depressive symptoms among adults with asthma [J]. American journal of public health,2006,96(5):873-879.
[26]Ekici A, EkiciM, KaraT, et al. Negative mood and quality of life in patients with asthma [J]. Quality of Life Research,2006,15(1):49-56.
[27]Allen GM, Hickie I, Gandevia SC.et al. Impaired voluntary drive to breathe:a possible link between depression and unexplained ventilatory failure in asthmatic patients [J].Thorax,1994, 49(9):881-884.
[28]Vamos M, Kolbe J. Psychological factors in severe chronic asthma[J]. Aust N Z J Psychiatry,1999,33(4):538-544.
[29]Mancuso CA, Peterson MG, Charlson ME. Effects of depressive symptoms on health-related quality of life in asthma patients[J]. J Gen Interm Med,2000,15(5):301-310.
[30]李雁,邵仲殿.子午流注纳子针法对哮喘症状及血清IL-4的影响[J].江西中医药,2009,41(10)：57-58.
[31]张小咏,陈淑萍,李小攀.哮喘日记对支气管哮喘病人生活质量的影响[J].护理研究2011,25(11)：2967-2968.
[32]衍君,李红艳.杜伟,李晶晶.护理干预对患儿哮喘日记记录依从性的影响[J].护理研究,2010,24(6)：1566-1567.
[33]何忠明,徐军,周晓芹等.支气管哮喘临床控制与睡眠呼吸障碍的关系[J].新疆医科大学学报,2010,33(9)：1067-1067.
[34]邱素琼.哮喘门诊患者健康教育效果评价与分析[J].中医药导报,2010,16(6)：117-119.
[35]GINA EXECUTIVE COMMITTEE AND GINA SCIENCE COMMITTEE,GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION 2008 [J] www.ginasthma.org,2008:50-51.
[36]Castro M, Kraft M. Clinical asthma[M]. Philadelphia:Elsevier Mosby,2008:449-457.
[37]Cluley S, Cochrane GM:Psychological disorder in asthma is associated with poor control and poor adherence to inhaled steroids. Respir Med.2001 Jan;95(1):37-39.
[38]Rietveld S, van Beest I, Everaerd W. Stress-induced breathlessness in asthma. Psychol Med 1999; 29(6):1359-1366.
[39]Sandberg S, Paton JY, Ahola S, McCann DC, McGuinness D, Hillary CR, Oja H. The role of acute and chronic stress in asthma attacks in children. Lancet 2000; 356(9234):982-987.
[2]王骏或,叶伟成.论温阳化瘀治哮喘[J].上海中医药杂志,1994,(9)：17-18.
[3]张蕴卓,刘贵颖.支气管哮喘的中医治疗进展[J].天津中医药大学学报,2006,25(4)：238-239.
[4]李传方,高尔鑫.哮喘病因病机及治则的探讨[J].安徽中医学院学报,1985,(4)：20-22.
[5]韩春生,张洪春.晁恩祥教授治疗哮喘病的经验[J].湖南中医药导报,1996,2(1)：9-10.
[6]孙继铭,薄庆,申兆义.从内风论治支气管哮喘90例分析[J].实用中医内科杂志,2003,17(5)：73.
[7]严桂珍,余传星,李希.益肾补肺平喘汤治疗支气管哮喘发作期42例临床观察[J].中国中医药科技,2000,7(6)：382-383.
[8]张丽玲.从治疗喘证2344人次中观察疏肝解郁法的疗效[J].江西中医药,1989,(2)；40.
[9]武维屏,贺福田.肝与咳、喘、哮[J].北京中医学院学报,1990,13(2)：11-13.
[10]高淑英.哮喘从肝肺论治探讨[J].中国中医药信息杂志,2006,13(8)：77.
[11]夏光欣.论肝与哮喘[J].陕西中医,1993,14(4)：161-162.
[12]王琳,田建辉.“痰饮伏肺”与哮喘病机[J].陕西中医,,2003,24(4)：334-336.
[13]贾仰民,宋康.中医学对哮喘的认识[J].光明中医,2010,25(5)：782-783.
[14]张洪春.祛风解痉法治疗哮喘病的临床研究[J].北京中医药大学学报,1995.18(4)：27-29.
[15]金亚明.祛风解痉汤治疗咳嗽变异性哮喘32例[J].黑龙江中医药,2008(1)：6-7.
[16]邢萍.宣肺降气汤治疗咳喘280例[J].河北中医,1993,15(1)：11-12.
[17]李霞,杜辕滨,江惠萍.降气定喘汤治疗支气管哮喘36例小结[J].甘肃中医,2002,15(2)： 31.
[18]杜宝荣.中西医结合内服外治治疗哮喘40例[J].四川中医,2004,22(6)：54.
[19]邵长荣,肖沪生,陈凤鸣,等.川芎嗪静脉滴注治疗发作期支气管哮喘[J].上海中医药杂志,1990,(8)：18-19
[20]崔红生,王小青,武维屏.升降散加减治疗支气管哮喘急性发作期临床观察[J]中国中医急症,2000,9(3)：96-97.
[21]张洁,施光其.黄芪六君子汤治疗哮喘缓解期85例临床观察[J].山东中医杂志,2004,23(4)：204-205.
[22]李向东,蒋雅萍,蔡寅寿.健脾益肺口服液治疗小儿哮喘缓解期50例[J].陕西中医,2003,24(6)：20-21.
[23]武维屏.调肝理肺法治疗哮喘174例临床观察[J].北京中医学院学报,1990,9(4)：19.
[24]郑彩霞.调肝理肺法治疗支气管哮喘85例临床观察[J].中医药临床杂志,2004,16(4)：311-312.
[25]赵四林,范伏元,贺选玲,等.加味二仙丸治疗支气管哮喘缓解期疗效观察[J].中国中医药信息杂志,2006,13(5)：59-60.
[26]林汉生.中西医结合治疗支气管哮喘慢性持续期临观察[J].实用中医药杂志,2005,21(5)：28.
[27]宋传荣.运用通腑法治疗慢性支气管炎的体会[J].现代中医药,2005,2：14-15.
[28]宋诵文.温肾健脾祛痰法控制支气管哮喘复发30例——附核酪注射液治疗对照22例[J].浙江中医杂志1998,33(1)：28-29.
[29]刘仁慧,袁颖,郭忻.哮喘缓解期治疗宜肺脾肾三脏并补[J].现代中西医结合杂志,2004,13(24)：141.
[30]李学明.中西医结合治疗缓解期支气管哮喘疗效观察[J].河北中医,2006,28(2)130-131.
[31]吴艳华.专科专病名医临证经验丛书2呼吸病[M].第2版.北京：人民卫生出版社,2006：142.
[32]张丽玲,李银珍,刘韶景.中医疏肝解郁法治疗喘证的研究[J].现代诊断与治疗,1993,4(1)：38-39.
[33]黄忠远,杨军平,邱丽瑛.解郁定喘汤治疗情志性支气管哮喘22例疗效观察[J].山东医药,2008,48(15)：61.
[34]张军,鲁焱.泻肺清肝饮治疗哮喘热哮证的疗效观察[J].湖北中医杂志,2010,32(9)：28-29.
[35]李淑霞,仝连伟,卢建华,等.哮喘患者生活质量与其应对方式和社会支持的相关性研究[J].护理学杂志,2007,22(15)：25-27.
[36]Kuo-An Chu, Yi-Chin Wu, Min—Hsim, Hong-Chung Wang. Acupuncture resulting in immediate bronchodilating response in asthma patients[J]. J Chin Med Assoc,2005,68(12): 591-594.
[37]马文珠,王莹.针刺和穴贴治疗支气管哮喘47例临床比较[J].中国针灸,2000,8(22)：455-456.
[40]老昌辉.自血混合丙球穴注治疗哮喘的临床观察[J].中国针灸,1995,15(6)：5-6,60.
[41]马淑兰,杨永清,崔龙萍,等.针刺血清对高嗜酸性粒细胞血症大鼠外周血嗜酸粒细胞数目的影响[J].针刺研究,2002,27(2)：65-68.
[42]Fan H, Sun B, Gu Q, et al. Oxygen radicals trigger activation of NF-kappaB and AP-1 and upregulation of IL-4 in reperfused canine heart [J]. Am J Physiol Heart Circ Physiol, 2002,282(5):H1778-1786.
[43]杨永清,陈汉平,王瑞珍,等.针刺对哮喘患者外周血活化T淋巴细胞与嗜酸性粒细胞的影响[J].上海针灸杂志,1995,14(2)：11-12.
[44]赖新生,李月梅,张家维.天灸对哮喘患者血清可溶性IL-2受体及T淋巴细胞亚群的影[J].中国针灸2000,20(1)：33-35.
[45]康晓娥,卓玉翠,赵福气,等.化脓灸对支气管哮喘发作期血浆中白三烯C4的影响[J].湖南中医杂志,2000,16(3)：33.
[46]马建吟,陆珊华,孙爱民.激光针疗改善过敏性豚鼠支气管滑肌功能的实验研究[J].江苏中医,2000,21(9)：45-46.
[47]王燕,刘艳艳,杨永清,等.针灸治疗支气管哮喘的实验研究进展[J].甘肃中医,2006,19(5)：40-43.
[48]戴文军,赖新生.天灸疗法对支气管哮喘患者血浆SP和VIP含量的影响[J].针刺研究,2001,26(2)：134-137.
[49]何扬子.激光灸治疗支气管哮喘的机理探讨[J].中国针灸1996,16(12)：7-9.
[50]蔡志红,董宇翔,刘放,等.针刺“清喘穴”即刻止喘多中心对照研究[J]中国针灸,2005,25(6)：383-386.
[51]张智龙,吉学群,薛莉,等.针刺治疗支气管哮喘急性发作期临床观察[J].中国针灸, 2005,25(3)：158-160.
[52]万文蓉.温阳利气法针灸治疗哮喘30例临床观察[J]中国针灸,2001.21(11)：649-650.
[53]李俊,赵吉平.电针肺俞穴为主治疗支气管哮喘急性发作期30例[J].中国民间疗法,2005,13(5)：15.
[54]孙玉霞,张争昌.罐针结合治疗哮喘急性发作129例观察[J].陕西中医学院学报,1998,21(4)：25-26.
[55]黄铁军,张吉,蔡普旺.针刺对哮喘患者外周血单个核细胞培养上清中IL—4分泌活性血清总IgE水平的影响[J].针刺研究,2000,25(4)：292-295.
[56].王丹华,卢锦花.单纯针刺、针刺结合穴位埋线疗法对支气管哮喘305例疗效观察[J].针灸临床杂志,1998,14(7)：32-34.
[57]董洪魁,范哗.刺络拔罐法治疗慢性哮喘46例[J].四川中医,2000,18(4)：55.
[58]徐懋兴,梁玉风.辨证施针治疗哮喘67例的疗效观察[J].针灸临床杂志,1994,10(2)：11-12.
[59]赵吉平,崔红生.温和灸治疗支气管哮喘缓解期36例疗效观察[J].中国民间疗法,2002,10(4)：22.
[60]洪建云.化脓灸治疗支气管哮喘临床研究[J].针灸临床杂志,2005,21(8)：39-40.
[61]刘明清,黄启嵩,尤斌.化脓灸治疗支气管哮喘的临床疗效观察[J].中国针灸,2002,22(8)：34-36.
[62]刘建平,徐斌,杨彬.穴位对氨茶碱经皮吸收的影响[J].中国针灸,2003,23(6)：355-357.
[63]宣丽华,徐福,张舒雁,等.穴位贴敷加穴位注射防治支气管哮喘的临床研究[J].中国针灸,2002,22(7)：9-11.
[64]王永兴,应延风,郭耿仁.曲安缩松穴位注射对哮喘患者肺功能改善作用[J].现代中西医结合杂志,2001,10(2)：95-96.
[65]侯小藏,王淑华.斯奇康穴位注射治疗哮喘58例[J].四川中医,2002.20(8)：81.
[66]雷励.穿山龙注射液穴位注射治疗重症支气管哮喘临床观察[J].中国中医急症,2005,14(5)：419,424.
[67]王强,李开选.定喘穴注射灭活卡介苗治疗支气管哮喘的观察[J].中国实用乡村医生杂志,2005,12(4)：41-42.
[68]李克刚.耳穴贴压治疗支气管哮喘58例[J].中国针灸,2000,20(11)：46.
[69]邢剑秋,韩燕.耳针从肝论治咳嗽性哮喘39例[J].江苏中医,2000,21(11)：44.
[70]田从豁,李以松,杨宏.皮下埋针治疗哮喘的初步观察[J].中国针灸,2002,22(3)：150-154.
[71]于雯,房恭,杨慎峭,等.火针对哮喘患者肺功能、IgE的影响及机制探讨[J].四 川中医,2004,22(12)：9-11.
[72]房恭火针对哮喘患者IL-4、IFN-γ的影响及机制探讨[J].山东中医药大学学报,2006,30(4)：304-305.
[73]杜善侠,吴延逊,崔联民.梅花针加艾灸治疗哮喘120例[J].中国针灸,2002,22(4)：221.
[74]陈月琴.梅花针加艾灸治疗支气管哮喘临床观察[J].实用中医内科杂志,2008,22(12)：96.
[75]李洁,魏建子,刘世敏.针灸治疗支气管哮喘的选穴用穴规律探析[J].针刺研究,2000,25(1)：78-80.
[76]刘立公,顾杰.哮喘的古代针灸治疗特点分析[J].上海针灸杂志,2000,19(5)：45-46.
[77]李俊.针灸治疗支气管哮喘临床研究思路[J].辽宁中医杂志2005,32(8)：823-824.
[78]Darko DF, Risch SC, Gillin JC, Golshan S. Association of beta-endorphin with specific clinical symptoms of depression[J]. Am J Psy chiatry,1992; 149 (9):1162-1167.
[79]Wenhe Z, Hechun L, Yucun S. The effect of electric acupuncture treatment on urinary MHPG-sulphate execretion in unmedicated schizophrenics[J]. Inter J Neuroscience,1981,14(3-4):179-182.
[80]王晓明,杨德本,黄慧,等.重复经颅磁刺激治疗抑郁症的初步研究[J].中华精神科杂志,2003,36(3)：50.
[81]廉南,雷中杰.针刺四神聪为主治疗厄瓜多尔籍焦虑症患者临床观察[J].成都中医药大学学报,,2001,24(3)：51-52.
[82]刘兰英,陆倩,王玲玲.电针对抑郁症患者氟西汀副作用的影响[J].浙江中医药大学学报,2007,31(4)：484-485.
[83]刘桂珍,藏云娟,刘爱珍.针灸加系统脱敏疗法治疗焦虑性神经症的疗效观察[J].上海针灸杂志,1998,17(4)：17-18.
[84]张民英.30例针罐结合治疗抑郁症的体会[J].中国实用医药.2007,2(33)：146.
[85]崔金波.针灸与心理疗法综合治疗抑郁发作36例[J].天津中医药,2003,20(2)65-66.
[86]庄礼兴,徐世芬.穴位埋线治疗抑郁性神经症47例临床观察[J].广州中医药大学学报,2009,26(1)：38-40.
[87]Kuo-An Chu, Yi-Chin Wu, Min-Hsim, Hong-Chung Wang. Acupuncture resulting in immediate bronchodilating response in asthma patients[J]. J Chin Med Assoc,2005,68(12): 591-594.
[88]金光亮；周东丰；苏晶；电针对慢性应激抑郁模型大鼠脑单胺类神经递质的影响[J].中华精神科杂志,1999；32(4)：220-222.
[89]郝伟.精神病学[M].4版,北京：人民卫生出版社.2001：119.
[90]张昶,谭程,高丹,等.近30年国内体针治疗支气管哮喘随机对照临床试验选穴及疗程设定规律分析[J].北京中医,2010,29(8)：571-574.
[91]杨甲三.针灸学[M].北京：人民卫生出版社,1997：69,352,276.
[92]陈华德,金灵青,娄冉,张丽敏.百会穴电针和埋线对慢性应激抑郁模型大鼠行为学及血清CORT和ACTH的影响[J].上海针灸杂志,2010：29(4)：244-247.
[1]Gerritsen J.Follow-up studies of asthma from childhood to adulthood[J].Paediatr Respir Rev,2002,3(3):184-192.
[2]程志英,王国洪,舒柳英,等.支气管哮喘与遗传和环境因素的关系[J].中国自然医学杂志,2003,5(2)：70-72.
[3]叶任高.内科学[M].4版,北京：人民卫生出版社,2001：32-33.
[4]王文莉,林洁英,林若玲.汕头市小儿支气管哮喘的吸入性变应原分析[J].河北医学,2005,10：46-47.
[5]Holtzman MJ, Agapov E, Kim E, et al. Developing the epithelial, viral, and allergic paradigm for asthma:Giles F. Filley lecture[J]. Chest,2003,123 (3 Suppl):377S-384S.
[6]Devereux G, Semon A.Diet as a risk factor for atopy and asthma[J].J Allergy Clin Immunol,2005,115(6):1109-1117.
[7]徐斌,王效道.心身医学[M].中国医药科技出版社,1986.
[8]Miller B D. Depression and asthma:a potentially lethal mixture [J]. J Allergy Clin Immunol 1987,80(3 Pt 2):481-486.
[9]Garden GM. Ayres J G. Psychiatric and social aspects of brittle asthma [J]. Thorax,1993, 48(5):501-505.
[10]Shih HZ. Eosinophils function as antigen-presenting cells[J]. J Leukoc Biol,2004,76 (3):520-527.
[11]Umetsu DT.Revising the immunological theories of asthma and allergy[J]. Lancet,2005,365(9454):98-100.
[12]李京培.在慢性哮喘患者血清中测定干扰素水平及其意义[J].中华医学检验杂志,1992,15(4)：212.
[13]James AL, Hogg JC,Dunn LA, et al. The use of the internal perimeter to compare airway-size and to calculate smooth muscle shortening[J]. Am Rev Respir Dis,1988,138 (1):136-139.
[14]武虹艳,万毅新,王晓平,等.轻、中度持续哮喘患者治疗前后气道高反应性及致气道重塑细胞因子变化研究[J].中国全科医生,2011,14(25)：58-60.
[15]Brew K,Dinakarpandian D,Nagase H. Tisse inhihit or metallop roteinase evolution, structure and function[J]. Biochim Biophys Acta,2000,1477(1-2):267-283.
[16]朱艳芬,宋泽庆,林磷.支气管哮喘小鼠气道重构模型的构建及评价[J].吉林大学学报(医学版),2010,36(1)：99-103.
[17]Crimi E, Spanevello A, Ind PW, et al. Dissoeiation between airway inflammation and airway hyperresponsiveness in allergie asthma[J]. Am ResPir Crit Care Med,1998; 157 (1):4-9.
[18]Kam JC, Szefler SJ, Surs w, et al. Combination IL-2 and IL-4 reduces glucocorticoid receptor-binding affinity and T cell response to glucocorticoids[J]. J Immunol,1993,151(7): 3460-3466.
[19]Shih Z. Eosinophils function as antigen-presenting cells[J]. J Leukoc Biol,2004,76 (3): 520-527.
[20]Tomita K et al. Attenuated production of intracellular IL-10 and IL-12 in monocytes from patients with severe asthma[J].Clin Immunol,2002.102 (3):258-266.
[21]Ryan JJ. Interleukin-4 and its receptor:essential mediators of the allergic response[J]. J Allergy Clin Immunol,1997,99 (1 Pt 1):1-5.
[22]Barnes PJ. Effect of nedocromil sodium on platet-activating factor induced airway responses[J].J Allergy Clinl Immunol,1993,92(1 Pt2):187-189.
[23]陈康.哮喘的炎症反应过程及治疗[J].国外医学呼吸系统分册,1995,15(3)：146.
[24]殷凯生.支气管哮喘的现代论断与治疗[J].国外医学呼吸系统分册,2004,24(1)：55.
[25]孙红霞,李艳琴,于英.白三烯受体拮抗剂对哮喘治疗作用的研究[J].医学综述,2003,9(8)：16-17.
[26]Salvi SS, Krishna MT, Sampson AP, et al. The ati-inflammatory elects of leukotriene —modifying drugs and their use in asthma[J]. Chest,2001,119(5):1533-1546.
[27]罗文侗.支气管哮喘研究进展及存在问题[J].中华结核和呼吸杂志,1995,18(3)：131-132.
[28]梁冰岳,刘又宁.重新认识与评价B2肾上腺能受体激动剂[J].中华结核和呼吸杂志,1995,18(3)：133-134.
[29]Kips JC, O'Connor BJ, Inman MD, et al. A long-term study of the artiinflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma [J]. Am J Respir Crit Care Med,2000,161(3 Pt 1):996-1001.
[30]陈大鹏,万朝敏.循证医学关于儿童哮喘治疗中一些问题探讨[J].临床儿科杂志,2005,23(1)：55-56.
[31]Brown R. Behavioral issues in asthma management[J].Allergy Asthma Proc,2001, 22(2):67-69.
[32]Scott KM, Von Korff M, Ormel J, et al. Mental disorders among adults with asthma: results from the world Mental Health Survey[J]. Gen Hosp Psychiatry,2007;29(2):123-133.
[33]Brown ES, Vigil L, Khan DA,et al.A randomized trial of citalopram versus placebo in outpatients with asthma and major depressive disorder:a proof of concept study[J]. Biol psychiatry,2005,58(11):856-870.
[34]Ross CJ, Davis TM, MacDonald GF. Cognitive-behavioral treatment combined with asthma education for adults with asthma and coexisting panic disorder[J]. Clin Nurs Res.2005 May;14(2):131-157.
[35]蓝宇涛.212例支气管哮喘患者焦虑状况分析[J].华南预防医学,2003,29(4)35-37.
[36]Ten Thoren C, Petermann F. Reviewing asthma and anxiety [J]. Resp Med, 2000,94(5):409-415.
[37]Badura K, Brzoza Z, Gorezyca P, et al. Anxiety and depression in bronchial asthrna[J]. Psychiatr Pol,2001,35(5):755-762.
[38]Goldney RD, Ruffin R, Fisher IJ. Asthma symptoms associated with depression and lower quality of life:a population survey [J]. Med J Aust,2003,178 (9):437-441.
[39]Kim L.L, Simon L.B, Silvana B, et al. What is worse for asthma control and quality of life:depressive disorders, anxiety disorders, or both? Chest 2006,130 (4):1039-1047.
[40]Melissa Opolske, Lan Wilson.Asthma and depression:a pragmatic review of the literature and recommendations for future research[J].Clin Pract Epidemol Ment Health,2005,1:18-25.
[41]Oraka E, MPH; King ME, Callahan DB, Asthma and serious psychological distress: prevalence and risk factors among US adults,2001 2007[J]. Chest,2010;137(3):609-616.
[42]孙宏伟,童莉,尹风铃,等.支气管哮喘患者的心理健康状况及影响因素研究[J].中国行为医学科学,1999,8(3)：190-191.
[43]Vila G, Nollet-Clemencon C, de Blic J, et al. Prevalence of DSM IV anxiety and affective disorders in a pediatric population of asthmatic children and adolescents [J]. J Affect Disord. 2000,58(3):223-231.
[44]王鑫,张亚京,梁昆仑,等.支气管哮喘患儿心理学特点及整合性心理治疗对其疗效影响[J].实用儿科临床杂志,2007,22(21)：1627-1629.
[45]刘春红,段熙明,石寿森,等.支气管哮喘患者的生存质量及相关因素[J].中国心理卫生杂志,2007,21(8)：553-555,562.
[46]李毅精.心理社会因素在哮喘发作中的作用[J].中华结核和呼吸杂志,1998：11：134.
[47]王琳,蔡映云,秦兴国,等.哮喘患者的心理情绪与社会支持[J].中华内科杂志,2000,39(3)：192-193.
[48]杨菊贤,张锡明.实用心身疾病学[M].乌鲁木齐：新疆科技卫生出版社,1992：155.
[49]Rietveld SP, Prins PJ. The relationship between negative emotions and acute subjective and objective symptoms of childhood asthma[J]. March,1998,28(2):407-415.
[50]Van Sciver MM, D'Angelo EJ, Rappaport L. Pediatric compliance and the roles of distinct treatment characteristics, treatment attitudes, and family stresss:a preliminary report [J]. J Dev Behav Pediatr,1995,16(5):350-358.
[51]何权瀛.社会心理因素在哮喘发病中防治中的作用[J]中华结核和呼吸杂志,2001：24(9)：518-519.
[52]郭伟安,向平超,鞠立新,等.心理社会因素与支气管哮喘相关性研究[J].临床肺科杂志,2006,11(6)：18-19.
[53]闫巧焕,王红阳,吕英刚.社会心理因素在支气管哮喘发病中的作用[J].华北煤炭医学院学报,2006,8(3)：304-305.
[54]谢启文.现代神经内分泌学[M].上海：上海医科大学出版社,1999：169.
[55]石寿森,王晓芝,张兰,等.支气管哮喘心理社会因素与细胞因子及内皮素变化的关系[J].中国心理卫生杂志,2004,18(8)：527-530.
[56]Lehrer P M, Lsenberg S, Hochron S M. Asthma and emotion:a review [J]. J Asthma, 1993,30(1):5-21.
[57]商鸣宇,高元明,粱瑛,等.心理因素与支气管哮喘[J].北京医学,2002,24(4)： 55-56.
[58]汪辉,黄美健.生活事件焦虑抑郁对支气管哮喘发病影响的探讨[J].浙江实用医学,1996(1)：22-23.
[59]罗茂红,来则民,王栋.心身因素与儿童哮喘关系的研究[J].中国心理卫生杂志,2001,16(1)：58-59.
[60]Brown ES,Suppes T,Khan DA, et al. Mood changes duning prednisone burs in outpatients with asthma[J]. Clin Psychophamacol,2002,22 (1):55-61.
[61]Potoczek A. Difficult asthma stress and panic disorder[J]. Psychiatr Poi,2005,39(1):51-66.
[62]马迎教,林健燕.心理干预对哮喘患者心理及Th1 Th2平衡的影响[J].现代预防医学,2010,37(17)：3292-3294.
[63]麦贤弟,赵莉,檀卫平,等.哮喘患儿IL-12、 IL-13与总IgE水平变化[J].中山医科大学学报,2000,21(5)：400-402.
[64]兰大荣,冼乐武,梁宗安,等.心理治疗对哮喘常规干预的影响[J].华西医学,2002,17(1)：72-73.
[65]王贤才.呼吸系统疾病的最新进展[M].青岛：青岛出版社,1996：69-73.
[66]De MaroD sJ. Relaxation as a holistic nursing intervention[J]. Holist NurS Pract, 2000,14(3):30.
[67]支气管哮喘的定义、诊断、严重度分级及疗效判定标准(修正方案).中华结核和呼吸杂志,1993,16(增刊)：5.
[68]Grokker B. Effectiveness of combined relaxation exercises for children with bronchial asthma[J]. Kinderarztl Prax,1992,60 (1):12-16.
[69]杨华彬,汤艳清,何晓玲.渐进式放松疗法对学龄儿童支气管哮喘的疗效[J].中国行为医学科学,2004,13(6)：36-38.
[70]Freeman L W,Welton D. Effects of imagery,critical thinking,and asthma education on symptoms and mood state in adult asthma patients:a pilot study[J]. J Altern Complement Med,2005,11(1):57-68.
[71]张绍敏,孙丽,黄津芳.放松训练对哮喘病人干预效果研究[J].中华护理杂志,1999,34(4)：200-202.
[72]Huntley A, White AR, Ernst E. Relaxation therapies for asthma:a systematic review[J]. Thorax,2002,57(2):127-131.
[73]Melissa Opolske, Lan Wilson. Asthma and depression:a pragmatic review of the literature and recommendations for future research[J]. Clin Pract Epidemol Ment Health,2005,1:18-25.
[74]Lechin F, van der Dijs B,Orozco B, et al. The serotonin uptake-enhancing drug tianeptine suppresses in children:A double-blind, crossover, placebo-controlled study[J]. J Clin Pharmacol,1998,38 (10):918-925.
[75]梁可云.支气管哮喘患者抗抑郁治疗的临床观察[J].中国现代医药杂志,2008,10(2)：92-93.
[76]刘希华,周乃娥.健康教育对提高哮喘病人疾病认知与自控水平的研究[J].实用心脑肺血管病杂志,2002,10(6)：42-43
[1]郑吉善,李昌崇,陈庆武,等.卡介菌多糖核酸对哮喘小鼠胸腺活化调节趋化因子及mRNA表达的影响[J].中国药理学通报,2007,23(5)：666-671.
[2]张克敏,白兆芝.中医内科学[M].北京：科学出版社,2001：25.
[3]孙滨.哮喘发病机理与治疗进展[J].中华结核和呼吸杂志,1994,17(4)：197.
[4]郭雪君,邓伟吾.B2激动剂在治疗哮喘中存在的问题[J].中华结核和呼吸杂志,1994,17(4)：203-205.
[5]Chu KA,Wu YC, Tmg YM, Wang HC, Lu JY. Acupuncture therapy results in immediate bronchodilating effect in asthma patients. J Chin Med Assoc.2007,70(7):265-268.
[6]Miller B D. Depression and asthma:a potentially lethal mixture [J]. J Allergy Clin Immunol,1987,80:481-486.
[7]Ross C J, Davis T M, Macdonald G F. Cognitive-behavioral treatment combined with asthma education for adults with asthma and coexisting panic disorder. Clin Nurs Res,2005, 14(2):131-157.
[8]GINA EXECUTIVE COMMITTEE AND GINA SCIENCE COMMITTEE.GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION 2008[J].www.ginathma.org,2008:20-21.
[9]中华医学会呼吸病学分会.支气管哮喘防治指南、支气管哮喘的定义、诊断、治疗和管理方案[J].中华结核和呼吸杂志,2008,31(3)：177-185.
[10]李明华,殷凯生,蔡映云,主编.哮喘病学.人民卫生出版社.2005,2566叶任高,陆再英,主编.内科学.人民卫生出版社.2007,68
[11]中华人民共和国国家质量监督检验检疫总局,中国国家标准化管理委员会发布.腧穴名称与定位[M].北京：中国标准出版社,2006.
[12]McDowell I. Measuring health:a guide to rating scales and questionnaires [M]. Oxford University Press,2006:303-304,344-345.
[13]胡亚美,江载芳.实用儿科学[M].7版.北京：人民卫生出版社,2002：631-642.
[14]杨锡强,易著文.儿科学[M].6版.北京：人民卫生出版社,2003：193-198.
[15]全国儿童哮喘防治协作组.中国城区儿童哮喘患病率调查[J].中华儿科杂志,2003,41(5)：123-127.
[16]张压西,陈友梅,余红樱.针刺肺输穴改善肺功能时效关系研究[J].中国针灸,1997,17(10)：581-582,641.
[17]刘鑫,戴爱国,周继鹏,等.针刺对哮喘豚鼠肺内嗜酸细胞凋亡及Fas表达的影响[J].上海针灸杂志,2003,22(7)：3-5.
[18]孙占玲.王伟.膻中穴埋线对哮喘豚鼠气道炎症的影响[J].浙江中医杂志,2007.42(7)：392-393.
[19]邱为尉.列缺穴为主治疗寒痰[J].上海针灸杂志,1999.18(3)：12.
[20]陈丽仪,郭元琦,凌楠.高频电针神庭印堂穴治疗不寐临床观察[J].新中医,2001,33(10)：46-47.
[21]郭乃琴,聂鸿丹.针刺加电针治疗焦虑症30例[J].针灸临床杂志,2002,18(11)：38.
[22]Bacharier LB, Strunk RC, Mauger D, et al. Classifying Asthma Severity in Children[J]. Am J Respir Crit Care Med..2004,170:426-432.
[23]王又平.针灸治疗哮喘50例临床观察[J].光明中医,2008,23(1)：23-24.
[24]徐永健,谢俊刚.重视对支气管哮喘患者的生活质量评估.中华内科杂志,2005,44(5)：324-325.
[25]Yen IH, Yelin EH, Katz P, et al. Perceived neighborhood problems and quality of life, physical functioning, and depressive symptoms among adults with asthma [J]. American journal of public health,2006,96(5):873-879.
[26]Ekici A, EkiciM, KaraT, et al. Negative mood and quality of life in patients with asthma [J]. Quality of Life Research,2006,15(1):49-56.
[27]Allen GM, Hickie I, Gandevia SC.et al. Impaired voluntary drive to breathe:a possible link between depression and unexplained ventilatory failure in asthmatic patients [J].Thorax,1994, 49(9):881-884.
[28]Vamos M, Kolbe J. Psychological factors in severe chronic asthma[J]. Aust N Z J Psychiatry,1999,33(4):538-544.
[29]Mancuso CA, Peterson MG, Charlson ME. Effects of depressive symptoms on health-related quality of life in asthma patients[J]. J Gen Interm Med,2000,15(5):301-310.
[30]李雁,邵仲殿.子午流注纳子针法对哮喘症状及血清IL-4的影响[J].江西中医药,2009,41(10)：57-58.
[31]张小咏,陈淑萍,李小攀.哮喘日记对支气管哮喘病人生活质量的影响[J].护理研究2011,25(11)：2967-2968.
[32]衍君,李红艳.杜伟,李晶晶.护理干预对患儿哮喘日记记录依从性的影响[J].护理研究,2010,24(6)：1566-1567.
[33]何忠明,徐军,周晓芹等.支气管哮喘临床控制与睡眠呼吸障碍的关系[J].新疆医科大学学报,2010,33(9)：1067-1067.
[34]邱素琼.哮喘门诊患者健康教育效果评价与分析[J].中医药导报,2010,16(6)：117-119.
[35]GINA EXECUTIVE COMMITTEE AND GINA SCIENCE COMMITTEE,GLOBAL STRATEGY FOR ASTHMA MANAGEMENT AND PREVENTION 2008 [J] www.ginasthma.org,2008:50-51.
[36]Castro M, Kraft M. Clinical asthma[M]. Philadelphia:Elsevier Mosby,2008:449-457.
[37]Cluley S, Cochrane GM:Psychological disorder in asthma is associated with poor control and poor adherence to inhaled steroids. Respir Med.2001 Jan;95(1):37-39.
[38]Rietveld S, van Beest I, Everaerd W. Stress-induced breathlessness in asthma. Psychol Med 1999; 29(6):1359-1366.
[39]Sandberg S, Paton JY, Ahola S, McCann DC, McGuinness D, Hillary CR, Oja H. The role of acute and chronic stress in asthma attacks in children. Lancet 2000; 356(9234):982-987.